The physiologic importance of parasympathetic influence on the sinoatrial and atrioventricular nodes is well established, but the importance of parasympathetic modulation of ventricular function remains controversial. Recognized effects of muscarinic cholinergic stimulation on ventricular automaticity and ventricular repolarization, the ability of muscarinic cholinergic agonists to antagonize catecholamine effects in the ventricle and proposed mechanisms for these effects are described. Anatomic studies have demonstrated a great abundance of cholinergic nerve endings in association with the ventricular conductingsystem. Stimulationof the vagusnerve or addition of muscarinic cholinergic agonists suppresses ventricular automaticity in most species and antagonizes isoproterenol-induced action potential shortening and isoproterenol-restored slow response action potentials. In vivo, interactions between the parasympathetic and sympathetic nervous systems occur at multiple levels. The parasympathetic nervous system regulates cardiac function not only directly, but also by means of parasympathetic modulation of sympathetic effects on the heart. The importance of parasympathetic influence on the sinoatrial and atrioventricular (AV) nodes is well established (1-5). Parasympathetic effects on ventricular electrical function have also recently been recognized to be physiologically important, and may also influence significantly the pathophysiologic milieu responsible for the initiation or termination of certain ventricular arrhythmias.
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The physiologic importance of parasympathetic influence on the sinoatrial and atrioventricular nodes is well established, but the importance of parasympathetic modulation of ventricular function remains controversial. Recognized effects of muscarinic cholinergic stimulation on ventricular automaticity and ventricular repolarization, the ability of muscarinic cholinergic agonists to antagonize catecholamine effects in the ventricle and proposed mechanisms for these effects are described. Anatomic studies have demonstrated a great abundance of cholinergic nerve endings in association with the ventricular conductingsystem. Stimulationof the vagusnerve or addition of muscarinic cholinergic agonists suppresses ventricular automaticity in most species and antagonizes isoproterenol-induced action potential shortening and isoproterenol-restored slow response action potentials. In vivo, interactions between the parasympathetic and sympathetic nervous systems occur at multiple levels. The parasympathetic nervous system regulates cardiac function not only directly, but also by means of parasympathetic modulation of sympathetic effects on the heart. The importance of parasympathetic influence on the sinoatrial and atrioventricular (AV) nodes is well established (1-5). Parasympathetic effects on ventricular electrical function have also recently been recognized to be physiologically important, and may also influence significantly the pathophysiologic milieu responsible for the initiation or termination of certain ventricular arrhythmias.
Muscarinic cholinergic agonists inhibit release of norepinephrine from sympathetic nerve terminals, inhibit catecholamine-stimulated adenylate cyclase activity and alter cyclic guanosine monophosphate (GMP) and possibly cyclic adenosine monophosphate (AMP) levels.
Evidence is also presented that, in vivo, parasympathetic effects on ventricular electrical function might influence the pathophysiologic milieu responsible for initiation or termination of certain ventricular arrhythmias. Vagal influences appear to be protective against certain digitalis-induced arrhythmias and protective in certain experimental acute myocardial infarctions. In human beings, there appears to be tonic vagal tone in the ventricle and vagal stimulation terminates certain types of ventricular tachycardia. The evidence presented supports a physiologic role of parasympathetic stimulation in altering ventricular electrical function.
The heart is regulated by both limbs of the autonomic nervous system. In the sinoatrial node, the parasympathetic nervous system predominates over the sympathetic nervous system in control of heart rate (3.6) . Atrioventricular nodal function is under balanced influence of the parasympathetic and sympathetic nervous systems (3) . The importance of resting parasympathetic tone on human ventricular refractoriness has only recently been postulated (7) .
Contrary to early histologic studies (8-10) that indicated an absence of parasympathetic innervation of the mammalian ventricle, more recent studies suggest the presence of parasympathetic nerve fibers distal to the AV node. The evidence includes histologic demonstration of sparse numbers of cholinergic nerve endings in the ventricular myocardium, but a great abundance of cholinergic nerve endings in ventricular conducting tissue of both canine and human hearts (11). Histochemical studies have also localized choline acetyltransferase , the enzyme that catalyzes the synthesis of acetylcholine within the ventricle. (12, 13) and have demonstrated the presence of acetylcholine in the ventricular myocardium (14) . In addition to the evidence establishing the presence of cholinergic nerves in the ventricles, mus-carinic cholinergic receptors on myocardial cells have been demonstrated directly with ligand-binding assays using [3H] quinuclidinyl benzilate to label the receptors (15, 16) . These receptors are located both in the ventricular myocardial cell and in the prejunctional sites in the sympathetic nerve terminals innervating the myocardium (17) ,
In this article, we will review evidence that parasympathetic innervation of the mammalian ventricle is physiologically important and has clinical implications in altering arrhythmogenesis. As background, we will review the in vitro effects of muscarinic cholinergic stimulation on ventricular electrophysiologic variables, present evidence for a direct, adrenergic independent vagal effect and proposed biochemical mechanisms of action of the vagus in the ventricle.
Electrophysiologic Effects of Acetylcholine in the Mammalian Ventricle
Though early publications noted that physiologically relevant concentrations of acetylcholine exerted no effect on Purkinje fibers (18) or ventricular muscle transmembrane action potentials (19) , more recent reports demonstrate significant effects of acetylcholine on ventricular electrical function. Evidence from both in vivo and in vitro studies has accumulated to support the important role of vagal stimulation on electrical function in the ventricle,
The effects of acetylcholine on ventricular chronotropy. These effects have been demonstrated in vivo and confirmed by in vitro microelectrode studies. Eliakim et al. (20) demonstrated a negative chronotropic response to vagal stimulation or infusion of acetylcholine in animals with a normal conduction system. After complete heart block was established, vagal stimulation or infusion of acetylcholine still produced a transient slowing of the idioventricular rate. Others (21) have reported a significant reduction in ventricular rate as a result of vagal stimulation in adenalectomized dogs after removal of the upper vertebral and stellate ganglia and section of the bundle of His. Similar results demonstrating a depressant effect of acetylcholine or vagal stimulation on idioventricular rates in the intact ventricle are reported (22, 23) . Using intracellular recording techniques, Bailey et al. (24) demonstrated in the canine bundle of His and right bundle branch, when rendered automatic by anatomic isolation in situ, that acetylcholine produced a significant negative chronotropic effect. Acetylcholine produced a depression of diastolic depolarization, and as automaticity was depressed, conduction in the specialized conducting system was augmented ( Fig. I) , Similar observations have also been made in canine cardiac Purkinje fibers (17, 25) .
Effects on ventricular action potential. Early electrocardiographic studies suggested an effect of acetylcholine on ventricular action potential characteristics. Fisch et al. [24] by permission of the Amencan Heart Association, Inc.) (26) showed that acetylcholine consistently increased T wave amplitude, independent of changes in extracellular potassium concentration. It was presumed from this observation that acetylcholine increased the rate of ventricular repolarization. Data from microelectrode experiments suggest the effects of acetylcholine on ventricular electrical function are species-dependent. In the dog, acetylcholine produces either no change (27) or shortens action potential duration (25) . Carmeliet and Ramon (28) reported that in sheep, acetylcholine prolongs the action potential, shifts the plateau in the positive direction, causes hyperpolarization of the maximal diastolic potential and increases the rate of diastolic depolarization. Similar observations were reported by Lipsius and Gibbons (29) . At lower potassium concentrations (K + 3.4 or 2.7 mM), the increase in diastolic depolarization leads to spontaneous all or none depolarization. Voltage clamp data from sheep demonstrate that these changes in action potential characteristics produced by acetylcholine are due to a reduction of the background current mainly carried by potassium (inward and outward rectifier) and to a lesser extent by sodium (and probably calcium). The slow inward current as well as the transient inward current are reduced in amplitude and slowed in time course by acetylcholine. The effects on diastolic depolarization are primarily due to a shift of the activation curve of the pacemaker current a few millivolts in the depolarizing direction, without a change in the rectifier ratio (30, 31) . VAGAL EFFECTS ON THE VENTRICLE lACC Vol 2, No.6 December 1983 '1200 Ochi and Hino (32) reported that in the guinea pig papillary muscle, superfusion of acetylcholine produces a reduction in action potential duration and a reduction in the plateau of the action potential. In ventricular muscle, repolarization may be due to a time-dependent decrease of inward calcium current (i,.) rather than an increase in outward potassium currents (33, 34) . Hino and Ochi (35) demonstrated that in guinea pig papillary muscle, acetylcholine produces a dose-dependent reduction in the amplitude of i., and no increase in the outward potassium currents. Thus, microelectrode studies have demonstrated, in the majority of mammalian species studied, that acetylcholine alters electrophysiologic variables in the ventricle. In general, acetylcholine depresses ventricular automaticity (except in the sheep) and produces slight, if any, alteration in action potential duration. In numerous experiments from our laboratory, acetylcholine has been found to produce no change in action potential duration in guinea pig ventricular or dog Purkinje fibers, but produces a negative chronotropic effect in Purkinje fibers of either species. free, high calcium solutions (27), suggesting that the effects of acetylcholine were specifically antiadrenergic.
Avian versus mammalian heart. The electrophysiologic effects of acetylcholine are more marked in the mammalian atria than in the mammalian ventricle. Biegon and Pappano (42) demonstrated in the avian ventricle, inhibition of calcium-dependent action potentials by cholinergic agonists by two different mechanisms. In embryonic ventricles, acetylcholine had no effect on calcium-dependent action potentials evoked in 25 mM potassium in the absence of isoproterenol. However, in ventricles of this group, acetylcholine or carbamylcholine inhibited action potentials which Accentuated Effects of Acetylcholine in the Presence of Simultaneous Adrenergic Stimulation Accentuated antagonism. Although acetylcholine is known to alter ventricular chronotropy, it is generally recognized that the effects of acetylcholine are greatly enhanced in the presence of simultaneous sympathetic stimulation (36) . This enhanced response to parasympathetic stimulation in the presence of simultaneous sympathetic tone has been termed accentuated antagonism (36) .
One of the earliest examples of accentuated antagonism was described by Rosenblueth and Simeone (37) . They noted that in anesthetized cats, the absolute reduction in heart rate produced by a given vagal stimulus was greater when the basal heart rate was increased by tonic sympathetic stimulation. Samaan (38) showed that the cardiac acceleration produced by strong sympathetic stimulation was overpowered by weak vagal activity. The accentuated effects of acetylcholine, or vagal stimulation in the presence of sympathetic stimulation have been confirmed by others (3, 39, 40) .
The ability of acetylcholine to antagonize catecholamineinduced electrophysiologic effects has been well established in vitro. Bailey et al. (27) demonstrated that acetylcholine inhibited isoproterenol-induced action potential shortening in normally polarized, paced cardiac Purkinje fibers (Fig.  2) . Acetylcholine also abolished isoproterenol-induced slow response action potentials in potassium depolarized canine cardiac Purkinje fibers (27) ( Fig. 3 ) or guinea pig papillary muscles (41) . Acetylcholine failed to antagonize action potential shortening in canine cardiac Purkinje fibers superfused with high calcium Tyrode's solution, or to antagonize calcium-dependent action potentials generated in sodium-
were augmentedby isoproterenol. Whencalcium-dependent action potentials were augmented by increasing the calcium concentration of the superfusate, acetylcholine did not inhibit the action potentials,
In avian ventricles, obtained 5 days after hatching, acetylcholineproduceda direct inhibitionof calcium-dependent action potentials and continued to inhibit indirectly action potentials augmented by isoproterenol . These electrophysiologic changes paralleled differences in total tissue cyclic adenosine monophosphate (AMP) observed between embryonic and hatched avian ventricles (Table I) . Whencyclic AMP levels were increased (ventricles from hatched chicks), acetylcholine produced a direct adrenergic-independent inhibition of calcium-dependent action potentials; however, when cyclic AMP levels were lower (embryonicventricles), acetylcholine produced an indirect adrenergic-dependent inhibition of calcium-dependent action potentials.
The avian ventricles obtained from hatched animals respond to muscarinic cholinergic stimulation in many respects like the mammalian atria, which have a recognized direct response to infusion of acetylcholine. The embryonic avian heart, on the other hand, behaves as many believe the mammalian ventricle behaves with acetylcholine stimulation, producing only indirect effects when applied in the presence of simultaneous sympathetic stimulation.
Proposed Mechanisms of Action of Muscarinic Cholinergic Stimulation in the Ventricle
Cholinergic inhibition of norepinephrine release from sympathetic terminals. The interaction between the sympathetic and parasympathetic nervous systems occurs at multiple levels, including interactions in the central nervous system, interneurally, the level of the myocardial cell sarcolemmal membrane and possibly within the myocardial cells (36, (43) (44) (45) (Fig. 4 ). An interneural interaction between the sympatheticand parasympathetic nervoussystems can be surmised by an acetylcholine-induced reduction in norepinephrine output from isolated perfused rabbit hearts. Acetylcholine perfusion produces a dose-dependent reduction in norepinephrine output and this effect is blocked by atropine (46) . Vagal stimulation producingendogenousacetylcholine causes a similar reduction in norepinephrine output in perfused hearts. The mechanism of this presynaptic effect is unknown. Possibilities include cholinergic interference with the calcium-dependent excitation-secretion couplingor muscarinic-induced hyperpolarization of the terminal membrane.
Cholinergic inhibition of norepinephrine release from sympathetic nerve terminals cannot be the sole mechanism responsible for cholinergic attenuation of the cardiac response to sympathetic stimulation, Both in isolated cat (47) and dog (48) hearts, acetylcholine antagonizes the positive inotropic effects of infused norepinephrine. At the cellular level, beta-adrenergic agonists are known to increase cyclic AMP levels (49, 50) , and enhancement of the slow inward current (i,,) occurs when cyclic AMP levels are increased (49, 51, 52) . Several investigators (53, 54) havedemonstrated that muscarinic agonists attenuate beta agonist-induced increases in steady state cyclic AMP levels, However, the mechanism of this attenuation is not yet entirely clarified, Myocardial cell receptor-mediated muscarinic cholinergic effect. Several possible intracellular sites of interaction between the sympathetic and parasympathetic nervous systems exist. First, muscarinic cholinergic agonists inhibitboth basal-and epinephrine-stimulated adenylate cyclase activity in preparations of the canine myocardium (55, 56) . The specific biochemical and molecular mechanisms by which activation of muscarinic receptors inhibits adenylate cyclase remain to be elucidated, yet it seems clear that muscarinic agonists can diminish tissue cyclic AMP levels by inhibiting catecholamine stimulation of adenylate cyclase.
Second, a possible interaction between cyclic guanosine monophosphate (OMP) and cyclic AMP is postulated, In cardiac tissues, stimulation of muscarinic cholinergic receptors results in increased cyclic OMP levels (57, 58) . Analogs of cyclic OMP mimic the direct effects of muscarinic agonists and decrease sinoatrial node automaticity (59), inhibit atrial slow response action potentials (60) and produce a negative inotropic effect on ventricular myocardium (61, 62) . However, elevation of cyclic GMP by nitroprusside, which does not interact with muscarinic receptors, does not mimic the inotropic (63, 64) , electrophysiologic (65, 66) or antiadrenergic (63, 67, 68) effects of acetylcholine. Additional arguments against a role of cyclic GMP in mediating certain physiologic effects are the observations that over a range of concentrations of muscarinic agonist, certain physiologic effects can be induced without changing cyclic GMP levels and that physiologic effects are evident before changes in total intracellular cyclic GMP content. Acetylcholine can decrease automaticity and shorten action potential duration in guinea pig atria apparently without any relation to cyclic GMP levels (65) . At present, the role of cyclic GMP in mediating muscarinic cholinergic effects remains unclear, with substantial bodies of evidence both supporting and arguing against an important role for this nucleotide.
Thus in the intact heart. evidence exists both for cholinergic inhibition of norepinephrine release from sympathetic terminals and a myocardial cell receptor-mediated muscarinic cholinergic effect. Multiple sites for myocardial cellular effects are postulated. Muscarinic cholinergic agonists inhibit adenylate cyclase activity and increase cyclic GMP. Additional intracellular effects of muscarinic cholinergic treated and control animals ( Fig. 5 and 6 ). The negative
Evidence for a Direct Effect of Acetylcholine on Ventricular Electrophysiologic Variables
As previously noted, acetylcholine is known to produce direct adrenergic-independent effects in the mammalian sinoatrial node tissue, atrial muscle and atrioventricular node tissue and is known to antagonize catecholamine effects in the mammalian ventricle. Numerous studies have demonstrated effects of muscarinic cholinergic stimulation on ventricular electrical function, but the majority of these studies were not designed specifically to evaluate the possibility that endogenous norepinephrine release might modify the effect of the cholinergic agonists. There is a continuous release of norepinephrine stores from postganglionic sympathetic terminals (69) that is reduced when the preganglionic sympathetic fibers are cut (70) . The possibility of the influence of endogenous norepinephrine in modifying or accentuating cholinergic effects has been taken into account in only a few electrophysiologic studies (28, 42) . Rardon and Bailey (71) demonstrated that muscarinic cholinergic stimulation produced a direct (adrenergic-independent) negative chronotropic response in isolated guinea pig ventricular strips. The chronotropic response to physostigmine was similar in reserpine-pretreated, tyramine- chronotropic response was not diminished by reserpine pretreatment or reserpine pretreatment plus propranolol. nor was it accentuated during simultaneous treatment with tyramine. Carmeliet and Ramon (28) demonstrated that the electrophysiologic effects of acetylcholine in sheep cardiac Purkinje fibers were not antagonized by the simultaneous treatment of the preparations with propranolol or phentolamine.
Evidence from these studies supports the hypothesis that muscarinic agonists are able to produce direct electrophysiologic effects because of postjunctional cellular effects independent of the presence of discernible adrenergic tone.
Effects of Muscarinic Cholinergic Stimulation in Intact Animals and Human Beings
Data have been presented demonstrating the anatomic presence of cholinergic innervation of the ventricle. the effects of muscarinic cholinergic stimulation on ventricul ar muscle and cardiac Purkinje fiber action potential characteristics. the ability of muscarinic cholinergic agonists to antagonize catecholamine effects and the ability of muscarinic cholinergic agonists to exert adrenergic-independent effects in the mammalian ventricle. This section will present data to support the notion that vagal effects alone or in combination with heightened adrenergic tone have important consequences in vivo. and that vagal stimulation may have an important role in regulating ventricular electrophysiologic variables. The vagus nerve may subserve a significant role in modifying the propensity for certain cardiac arrhythmias.
Role in genesis of arrhythmias. Both limbs of the autonomic nervous system play important roles in the genesis of arrhythmias. Stimulation of specific sites in the central nervous system results in arrhythmias that suggest enhanced parasympathetic discharge. that is, sinus bradycardia, atrial asystole, atrial flutter and atrial fibrillation (72) . Parasympathetic stimulation may induce arrhythmias by depressing the sinus pacemaker, depressing or blocking AV conduction or altering the repolarization rate of regions of the myocardium (73) . Cholinergic stimulation shortens the atrial refractory period and is associated with induction and prolongation of atrial fibrillation (74) (75) (76) . The arrhythmogenic effects of central nervous system stimulation probably result from interaction between both the parasympathetic and sympathetic nervous systems. Vagal effects are pronouncedduring periods of heightened sympathetic tone.
Protective effect on ventricular arrhythmias. The influen ce of vagal stimulation on the occurrence of ventricular arrhythmias has been recognized for many years. In 1859, Einbrodt (77) used an inductorium to provoke ventricular fibrillati on in dogs. He delivered increasing current by approximating the coils and measured the ventricular fibrillation threshold by changing the distance between the coils. In the control state, ventricular fibrillation was provoked at a coil distance of 90 e rn, During vagal stimulation, the spacing could be narrowed to 30 ern before ventricular fibrillation occurred. Einbrodt concluded like other investigators since then (78) (79) (80) that vagal stimulation was protective against ventricular arrhythmias. Vagomimetic drugs (81, 82) protect against, while vagotomy and vagolytic drugs (83, 84) predispose to ventricular arrhythmias.
Though the influence of vagal stimulation on ventricular arrhythmias is recognized, the mechanisms of this protective effect are only poorly understood. Kolman et al. (85) demonstrated a protective effect of vagal stimulation on the threshold for ventricular fibrillation only during periods of enhanced sympathetic activity. Similarly, Rabinowitz et al. (86) . using the repetitive extrasystole threshold technique, demonstrated that methylcholine chloride produced a large increase in the ventricular fibrillation threshold in anesthetized dogs. Methylcholine infusion was associated with a decrease in arterial blood pressure and a reflex sinus tachycardia suggesting a high level of sympathetic tone. Betaadrenergic blockade induced with propranolol resulted in an increase in the repetitive extrasystole threshold which was not increased further by simultaneous administration of methylcholine. Martins and Zipes (87) demonstrated that in :x -chloralose anesthetized dogs, vagal stimulation prolonged the effective refractory period of the left ventricular epicardium. endocardium and left septum to a similar degree. Sympathetic denervation of the heart reduced this effect and pretreatment with propranolol eliminated vagal-inducedpro-VAGAL EFFECTS ON THE VENTRICLE JACC Vol 2. No 6
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Evidence for both a direct as well as indirect muscarinic effect is suggested by the work of Amlie and Refsum (88) . They demonstrated in pentobarbital-anesthetized dogs (to induce a high sympathetic background activity) that vagal stimulation produced a slight increase in right ventricular monophasic action potential duration (139 to 147 ms) when the heart was paced at a fixed rate (cycle length of 350 ms) . After beta-adrenergic receptor blockade with atenolol (0.5 mg/kg), monophasic action potential duration was increased but vagal stimulation still produced a further increase in action potential duration (147 to 152 ms at a cycle length of 350 ms). They found similar increases in ventricular functional and effective refractory periods with vagal stimulation before and after beta-adrenergic receptor blockade.
Role in digitalis-induced arrhythmias. Vagal influences may play an important role in regulation of arrhythmias that occur under various clinical situations. Digitalis in toxic doses increases the neural activity in cardiac sympathetic and parasympathetic nerves (89) (90) (91) (92) . Digitalis-induced hyperactivity in cardiac sympathetic nerves can be depressed by diphenylhydantoin (90) , propranolol (89), clonidine (91) and chlordiazepoxide (93) . These drugs result in a reduction of neural activity and an abolition of digitalisinduced cardiac arrhythmias. The intact parasympathetic nervous system appears to be protective against digitalisinduced arrhythmias. Sectioning of the vagus nerves decreases the dose of ouabain, digoxin and acetylstrophanthidin needed to produce cardiac arrhythmias (94).
Ventricular arrhythmias in experimental coronary occlusion and myocardial infarction. As in the case of digitalis, coronary artery occlusion results in increased neural activity in cardiac sympathetic and parasympathetic nerves (90, 95) . Sympathetic hyperactivity may occur in an asynchronous manner (96) . Both homogenous sympathetic and asynchronous sympathetic stimulation may be important in the generation of early ventricular arrhythmias occurring after coronary artery occlusion . (97) (98) (99) have demonstrated that. in fact. vagal stimulation is protective during acute myocardial infarction. Kent et al. (98) demonstrated that disparity of ventricular refractory periods decreased as the heart rate was increased in nonischemic myocardium (but increased in ischemic myocardium) and that vagal stimulation raised the ventricular fibrillation threshold in dogs . Myers et al. (99) demonstrated that vagal stimulation and bradycardia were associated with a postponement or prevention of ventricular fibrillation. Others (100-102) have also demonstrated a beneficial effect of vagal stimulation in experimentally induced acute coronary artery occlusion.
Several investigators
Experimental results examining the vagolytic effects of atropine in the setting of acute myocardial infarction are inconsistent. Atropine has been shown to be beneficial, harmful and without effect in this setting. Corr and Gillis (100) demonstrated that atropine (I mg/kg) increased the incidence of ventricular fibrillation after anterior myocardial infarction, whereas no effect was seen after inferior myocardial infarction. LeRoy et al. (103) reported that atropine (0.2 mg/kg) reduced the incidence of ventricular fibrillation after circumflex coronary occlusion in both the anesthetized and conscious dog. Corr and Gillis ( 10 I) concluded that in experimental animals , a deleterious response to atropine is encountered when: 1) anterior myocardial infarction is present; 2) atropine is administered during the early hours after ischemia; and 3) the ventricular premature complexes have short coupling intervals. Bilateral vagotomy increases the mortality rate and incidence of ventricular fibrillation following left anterior descending artery occlusion in the cat (100, 102) . These studies suggest that atropine and bilateral vagotomy may be detrimental under certain experimental conditions in the setting of acute myocardial ischemia . In clinical studies, atropine has been demonstrated to be beneficial in some patients. The therapeutic value of atropine is to correct bradycardia or heart block, or both, and to relieve hypotension. This clinical situation occurs primarily in patients with inferior myocardial infarction, and differs from those experimental settings previously mentioned where atropine and bilateral vagotomy result in a detrimental effect.
Mechanisms of protective effect. The mechanisms responsible for this protective effect of vagal stimulation after coronary artery ligation are not well defined. Arrhythmias occurring during the early interval after myocardial ischemia may be due to a reentrant mechanism, whereas arrhythmias occurring several hours after myocardial ischemia are primarily the result of increased automaticity (103) (104) (105) . According to Wit and Bigger (105) , "transmembrane action potentials have not been recorded from ischemic myocardium in the in situ heart during the early phase of ventricular arrhythmias, so that the actual cellular electrical events which accompany these arrhythmias are a matter of conjecture. " Though the cellular electrical event s responsible for these arrhythmias are unknown, microelectrode studies suggest possible theoretical benefits of vagal stimulation . In vitro microelectrode studies (17, 24) have demonstrated that acetylcholine decreases phase four depolarization, increases maximal diastolic potential and improves conduction velocity secondary to an increase in the velocity of the upstroke , particularly if the response is premature (17) . These effects of muscarinic cholinergic stimulation are most likely due to increased potassium conductance and would be expected to improve conduction velocity and possibly eliminate a slowed reentrant pathway . Additionally, acetylcholine suppresses slow response electrical activity and antagonizes catecholamine-induced effects in the ventricle.
These effects alone or in combination may play a role in the protective effect of vagal stimulation during acute myocardial ischemia.
Clinical implications. The importance of vagal effects
in the human ventricle has only recently been proposed by Prystowsky et al. (7) , who studied the effects of autonomic blockade on ventricular refractoriness in human beings. They demonstrated that elimination of tonic muscarinic cholinergic activity shortens ventricular refractoriness determined in the right ventricular apex in humans. Their data suggested a lack of significant background sympathetic tone as well. Because the effect of atropine occurred during beta-adrenergic blockade, it appears that muscarinic cholinergic activity did not require background sympathetic tone to exert its effect on the human right ventricle, but directly prolonged ventricular refractoriness.
Waxman et al. (106) reported termination of ventricular tachycardia in 5 patients, and in a later report (107) described termination of ventricular tachycardias in an additional 12 of 13 patients by infusion of phenylephrine. Phenylephrine produces hypertension and reflexly produces an increase in vagal tone. In 4 of these 12 patients studied in greater detail, edrophonium (15 to 20 mg, intravenously) decreased, whereas atropine (2.4 mg, intravenously) increased the dose of phenylephrine required to abolish ventricular tachycardia. Carotid sinus massage after pretreatment with edrophonium in high doses terminated ventricular tachycardia in these four patients. These data suggest that high levels of parasympathetic tone terminated ventricular tachycardia in these selected patients.
Although the precise electrophysiologic mechanisms responsible for specific instances of ventricular tachycardia in human beings cannot be elucidated, ample data from animal and human experiments indicate that, under appropriate circumstances, vagal stimulation or cholinergic agonists exert significant effects on ventricular excitability, refractoriness, automaticity and conduction speed. These direct and indirect electrophysiologic effects of the vagus nerve may alter substantially the propensity for the development or termination of ventricular arrhythmias.
